Naltrexone Implant for the Treatment of Polydrug Dependence: A Randomized Controlled Trial
Jari Tiihonen, M.D., Ph.D.; Evgeny Krupitsky, M.D., Ph.D.; Elena Verbitskaya, Ph.D.; Elena Blokhina, M.D., Ph.D.; Olga Mamontova, M.D.; Jaana Föhr, M.D.; Pekka Tuomola, M.D., Ph.D.; Kimmo Kuoppasalmi, M.D., Ph.D.; Vesa Kiviniemi, Ph.D.; Edwin Zwartau, M.D., Ph.D.
From the Department of Forensic Psychiatry, University of Eastern Finland, and Niuvanniemi Hospital, Kuopio, Finland; the Department of Clinical Physiology, Kuopio University Hospital, Kuopio; the Finnish Medicines Agency, Kuopio; the Department of Mental Health and Alcohol Research, National Institute for Health and Welfare, Helsinki; the Helsinki Deaconess Institute, Helsinki; the Department of Clinical Neuroscience, Karolinska Institutet, Stockholm; the St. Petersburg Bekhterev Psychoneurological Research Institute and Valdman Institute of Pharmacology, St. Petersburg Pavlov State Medical University, St. Petersburg, Russia.
Am J Psychiatry 2012;169:531-536.
doi:10.1176/appi.ajp.2011.11071121
Purchase Online access to this article for 24 hours
Clicking on the buy now link will redirect you to the shopping cart at APPI.org where you will be asked to log in or create an account to complete your transaction. Once your transaction is complete, you will receive an email with instructions for accessing this content online and in PDF format.
You may view, download, and/or print the article for your personal, scholarly, research, and educational use. You may not (i) distribute a copy
(electronic or otherwise) of the article without the written permission of APA, (ii) post the article on an electronic bulletin board or web
site, or (iii) charge for a copy (electronic or otherwise) of the article.